Oral idarubicin as a palliative agent in leukemia
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 1991-01, Vol.9 (1), p.59-60 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 60 |
|---|---|
| container_issue | 1 |
| container_start_page | 59 |
| container_title | Hematological oncology |
| container_volume | 9 |
| creator | Davis, C. L. Rohatiner, A. Z. S. Amess, J. A. L. Lister, T. A. |
| description | |
| doi_str_mv | 10.1002/hon.2900090108 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80595944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80595944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3638-82ce3d1fcd14fc78703ea33d29aa8940b93c9fc5f764ea6fb876a08a20054d703</originalsourceid><addsrcrecordid>eNqFkElPwzAQhS0EgrJcuSHlAreUsZ3E9hFVrKqokFgkLtbUccDUTYvdsPx7UqWi4sRpDu97b2YeIYcU-hSAnb7O6j5TAKCAgtwgPQpKpRQKtUl6wIRMgXG2Q3ZjfFtSCuQ22aaCQq7yHqGjgD5xJYZm7IyrE4wJJnP03uHCfdgEX2y9SFrB22Zipw73yVaFPtqD1dwjDxfn94OrdDi6vB6cDVPDCy5TyYzlJa1MSbPKCCmAW-S8ZApRqgzGihtVmbwSRWaxqMZSFAgSGUCelS29R0663HmYvTc2LvTURWO9x9rOmqjl8gGVZS3Y70ATZjEGW-l5cFMM35qCXnak2470uqPWcLRKbsZTW67xrpRWP17pGA36KmBtXFxjSuZcKNVyquM-nbff_2zVV6PbPzekndfFhf369WKY6EJwkeun20v9yNlQsJs7_cx_APL8jS4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80595944</pqid></control><display><type>article</type><title>Oral idarubicin as a palliative agent in leukemia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Davis, C. L. ; Rohatiner, A. Z. S. ; Amess, J. A. L. ; Lister, T. A.</creator><creatorcontrib>Davis, C. L. ; Rohatiner, A. Z. S. ; Amess, J. A. L. ; Lister, T. A.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.2900090108</identifier><identifier>PMID: 1710595</identifier><identifier>CODEN: HAONDL</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Acute leukemia ; Administration, Oral ; Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Chronic myeloid leukemia ; Humans ; Idarubicin ; Idarubicin - administration & dosage ; Idarubicin - therapeutic use ; Leukemia - drug therapy ; Medical sciences ; Palliative Care ; Pharmacology. Drug treatments</subject><ispartof>Hematological oncology, 1991-01, Vol.9 (1), p.59-60</ispartof><rights>Copyright © 1991 John Wiley & Sons, Ltd</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3638-82ce3d1fcd14fc78703ea33d29aa8940b93c9fc5f764ea6fb876a08a20054d703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.2900090108$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.2900090108$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19853799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1710595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davis, C. L.</creatorcontrib><creatorcontrib>Rohatiner, A. Z. S.</creatorcontrib><creatorcontrib>Amess, J. A. L.</creatorcontrib><creatorcontrib>Lister, T. A.</creatorcontrib><title>Oral idarubicin as a palliative agent in leukemia</title><title>Hematological oncology</title><addtitle>Hematol. Oncol</addtitle><subject>Acute leukemia</subject><subject>Administration, Oral</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Chronic myeloid leukemia</subject><subject>Humans</subject><subject>Idarubicin</subject><subject>Idarubicin - administration & dosage</subject><subject>Idarubicin - therapeutic use</subject><subject>Leukemia - drug therapy</subject><subject>Medical sciences</subject><subject>Palliative Care</subject><subject>Pharmacology. Drug treatments</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkElPwzAQhS0EgrJcuSHlAreUsZ3E9hFVrKqokFgkLtbUccDUTYvdsPx7UqWi4sRpDu97b2YeIYcU-hSAnb7O6j5TAKCAgtwgPQpKpRQKtUl6wIRMgXG2Q3ZjfFtSCuQ22aaCQq7yHqGjgD5xJYZm7IyrE4wJJnP03uHCfdgEX2y9SFrB22Zipw73yVaFPtqD1dwjDxfn94OrdDi6vB6cDVPDCy5TyYzlJa1MSbPKCCmAW-S8ZApRqgzGihtVmbwSRWaxqMZSFAgSGUCelS29R0663HmYvTc2LvTURWO9x9rOmqjl8gGVZS3Y70ATZjEGW-l5cFMM35qCXnak2470uqPWcLRKbsZTW67xrpRWP17pGA36KmBtXFxjSuZcKNVyquM-nbff_2zVV6PbPzekndfFhf369WKY6EJwkeun20v9yNlQsJs7_cx_APL8jS4</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>Davis, C. L.</creator><creator>Rohatiner, A. Z. S.</creator><creator>Amess, J. A. L.</creator><creator>Lister, T. A.</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910101</creationdate><title>Oral idarubicin as a palliative agent in leukemia</title><author>Davis, C. L. ; Rohatiner, A. Z. S. ; Amess, J. A. L. ; Lister, T. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3638-82ce3d1fcd14fc78703ea33d29aa8940b93c9fc5f764ea6fb876a08a20054d703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Acute leukemia</topic><topic>Administration, Oral</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Chronic myeloid leukemia</topic><topic>Humans</topic><topic>Idarubicin</topic><topic>Idarubicin - administration & dosage</topic><topic>Idarubicin - therapeutic use</topic><topic>Leukemia - drug therapy</topic><topic>Medical sciences</topic><topic>Palliative Care</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis, C. L.</creatorcontrib><creatorcontrib>Rohatiner, A. Z. S.</creatorcontrib><creatorcontrib>Amess, J. A. L.</creatorcontrib><creatorcontrib>Lister, T. A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis, C. L.</au><au>Rohatiner, A. Z. S.</au><au>Amess, J. A. L.</au><au>Lister, T. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral idarubicin as a palliative agent in leukemia</atitle><jtitle>Hematological oncology</jtitle><addtitle>Hematol. Oncol</addtitle><date>1991-01-01</date><risdate>1991</risdate><volume>9</volume><issue>1</issue><spage>59</spage><epage>60</epage><pages>59-60</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><coden>HAONDL</coden><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>1710595</pmid><doi>10.1002/hon.2900090108</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 1991-01, Vol.9 (1), p.59-60 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80595944 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Acute leukemia Administration, Oral Antineoplastic agents Biological and medical sciences Chemotherapy Chronic myeloid leukemia Humans Idarubicin Idarubicin - administration & dosage Idarubicin - therapeutic use Leukemia - drug therapy Medical sciences Palliative Care Pharmacology. Drug treatments |
| title | Oral idarubicin as a palliative agent in leukemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A11%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20idarubicin%20as%20a%20palliative%20agent%20in%20leukemia&rft.jtitle=Hematological%20oncology&rft.au=Davis,%20C.%20L.&rft.date=1991-01-01&rft.volume=9&rft.issue=1&rft.spage=59&rft.epage=60&rft.pages=59-60&rft.issn=0278-0232&rft.eissn=1099-1069&rft.coden=HAONDL&rft_id=info:doi/10.1002/hon.2900090108&rft_dat=%3Cproquest_cross%3E80595944%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80595944&rft_id=info:pmid/1710595&rfr_iscdi=true |